hydromorphone and Addiction, Opioid

hydromorphone has been researched along with Addiction, Opioid in 105 studies

Research

Studies (105)

Timeframe	Studies, this research(%)	All Research%
pre-1990	21 (20.00)	18.7374
1990's	9 (8.57)	18.2507
2000's	15 (14.29)	29.6817
2010's	41 (39.05)	24.3611
2020's	19 (18.10)	2.80

Authors

Authors	Studies
Fairbairn, N; Harris, MT; Nolan, S; Seliga, RK; Turnbull, J; Walley, AY; Weinstein, ZM	1
Antoniou, T; Bayoumi, AM; Campbell, T; Gomes, T; Kolla, G; Leece, P; McCormack, D; Srivastava, A; Strike, C; Young, S	1
Bozinoff, N; Le Foll, B; Rubin-Kahana, DS; Tardelli, VS	1
Cassella-Mclane, G; Choucair, I; Durant, TJS; El-Khoury, JM; Vera, MA; Villalba, CF	1
Bansback, N; Byres, D; Dobischok, S; Harrison, S; MacDonald, S; Marchand, K; Matzinger, E; Metcalfe, R; Oviedo-Joekes, E; Palis, H; Schechter, M	1
Caputo, A; Christopher, C; Compton, P; Delgado, MK; Lowenstein, M; McFadden, R; Olenik, JM; Perrone, J; Ronning, K; Sigueza, AL; Thakrar, AP; Uritsky, TJ; Winston, A	1
Balanza, G; Bharadwaj, KM; Bittner, EA; Das, P; Deng, H; Gutierrez, R; Horgan, C; Houle, TT; Johnson, JJ; Liu, R; Macdonald, T; Pandit, A; Purdon, PL; Santa Cruz Mercado, LA; Stone, TAD; Tou, SLJ	1
Cohen, MJ; Ocker, AC; Schwenk, ES; Shah, NB; Viscusi, ER; Witkowski, TA	1
Fairbairn, N; Goyer, MÈ; Le Foll, B; MacDonald, S; Meador, K; Oviedo-Joekes, E; Perreault, M; Ross, J; Sutherland, C; Trew, M; Turnbull, J	1
Barrett, FS; Bigelow, GE; Brands, B; Dunn, KE; Marsh, DC	1
Brar, R; McAdam, M; Young, S	1
Foreman, J; Harrison, S; MacDonald, S; Marchand, K; Oviedo-Joekes, E; Schechter, MT	1
Brar, R; Nolan, S; Sutherland, C; Wilson, T	1
Bromley, LA	1
Betsos, A; Boyd, J; Culbertson, C; Ivsins, A; Kerr, T; Mayer, S; McNeil, R; Olding, M; Sutherland, C	1
Brissette, S; Guh, D; Harrison, S; MacDonald, S; Marsh, DC; Oviedo-Joekes, E; Palis, H; Schechter, MT	1
Arishenkoff, S; Azar, P; Griesdale, D; Krausz, RM; Mathew, N; Moe, J; Nikoo, M; Schütz, CG; Sidhu, JA; Suen, JG; Vogel, M; Westenberg, JN; Wong, JSH; Wong, JYC	1
Haines, M; O'Byrne, P	1
Agin-Liebes, G; Bigelow, GE; Edwards, RR; Gruber, VA; Huhn, AS; Smith, MT; Strain, EC; Tompkins, DA	1
Beck, O; Böttcher, M; Keller, T; Lierheimer, S; Monticelli, FC	1
Hernandez, NM; Parry, JA; Taunton, MJ	1
Anis, AH; Brissette, S; Guh, D; Harrison, S; Janmohamed, A; Jutha, S; Krausz, M; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Schechter, MT; Zhang, DZ	1
Anis, AH; Brissette, S; Guh, D; Harrison, S; Krausz, M; Lock, K; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Palis, H; Schechter, MT	2
Coe, MA; Comer, SD; Jones, JD; Kelsh, D; Kim, S; Levy-Cooperman, N; Lofwall, MR; Nuzzo, PA; Sheldon, B; Tiberg, F; Vince, B; Walsh, SL	1
Holland, TL; Neuss, MJ	1
Bynum, ND; Flegel, R; Grabenauer, M; Hayes, ED; Mitchell, JM; Moore, KN; White, RM	2
Black, RA; Butler, SF; Cassidy, TA; McNaughton, EC	1
Febres-Aldana, CA; Hernandez Howard, L	1
Anis, AH; Bansback, N; Brissette, S; Guh, D; Harrison, S; Janmohamed, A; Krausz, M; MacDonald, S; Marsh, DC; Oviedo-Joekes, E; Schechter, MT	1
Barbic, S; Burghardt, J; Choi, F; Frank, A; Jang, K; Krausz, M; Nikoo, M; Schütz, C; Song, MJ; Tabi, K; Vogel, M; Zafari, Z	1
Linas, BP	1
Blackney, KA; Edwards, DA; Kamdar, NV; Liu, CA	1
Bruera, E	1
Guevara, M; Hofilena, D; Mikel, C; West, R	1
Bigelow, GE; Edwards, RR; Huhn, AS; Smith, MT; Strain, EC; Tompkins, DA	1
Barrett, AC; Braeckman, R; Guenther, S; Kelsh, D; Mickle, TC; Smith, A; Vince, B	1
Anis, AH; Brissette, S; Guh, D; Harrison, S; Lock, K; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Palis, H; Schechter, MT	1
Chang-Chien, GC; Chu, SK; Joseph, P; McCormick, Z	1
Gregory, TB	1
Bruera, E; Hui, D; Kwon, JH; Reddy, A; Tanco, K	1
Christensen, C; Gupta, D; Soskin, V	1
Black, RA; Butler, SF; Chilcoat, HD; Coplan, PM; McNaughton, EC; Weber, SE	1
Anis, AH; Brissette, S; Chettiar, J; Lock, K; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Schechter, MT	1
Guh, D; Lock, K; MacDonald, S; Marchand, K; Oviedo-Joekes, E; Schechter, MT	1
Duse, G; Ferrari, R; Visentin, M; Zanolin, ME	1
Fudala, PJ; Greenwald, MK; Heidbreder, C; Jones, JP; Liu, Y; Nasser, AF; Twumasi-Ankrah, P; Vince, B	1
Broglio, K; Walsh, AF	1
Kharasch, S; Kostic, M; Schultz, ML	1
Holtman, JR; Lofwall, MR; Nuzzo, PA; Walsh, SL	1
Firnhaber-Burgos, JB; Grewal, PK	1
Anis, A; Brissette, S; Guh, D; Krausz, M; Marsh, DC; Nosyk, B; Oviedo-Joekes, E; Schechter, MT	1
Bigelow, GE; Correia, CJ; Duke, AN; Strain, EC; Walsh, SL	1
Bigelow, GE; Lanier, RK; Lofwall, MR; Mintzer, MZ; Strain, EC	1
Eipe, N; Penning, J	1
Greenwald, MK; Lundahl, LH; Steinmiller, CL	1
Bigelow, GE; Dong, Q; Gastfriend, DR; Preston, KL; Schmittner, J	1
Kahan, M; Mailis-Gagnon, A; Srivastava, A; Wilson, L	1
Barrett, SP; Fulton, HG; Macisaac, C; Stewart, SH	1
Hale, ME; Kutch, M; Nalamachu, SR	1
Bryson, JR; Hannon, B; Zimmermann, C	1
Eap, CB; Melichar, JK; Myles, JS; Nutt, DJ	1
Greenwald, MK; Hursh, SR	1
Bigelow, GE; Carroll, CP; Preston, KL; Strain, EC; Walsh, SL	1
Bueller, J; Chang, Y; Greenwald, M; Johanson, CE; Kilbourn, M; Koeppe, R; Moody, DE; Zubieta, JK	1
Bigelow, GE; Correia, CJ; Strain, EC; Walsh, SL	1
Di Marino, ME; Haddox, JD; Smith, MY	1
Bigelow, GE; Harrison, JA; Lanier, RK; Nuwayser, ES; Umbricht, A	1
Eipe, N; Kay, J	1
Baskerville, JC; Brands, B; Gowdey, CW; Hirst, M	1
Lincoln, CA; McBride, DC; McCoy, CB; Rivers, JE	1
Gallinatti, JJ	1
Bigelow, G; Liebson, I; McCaul, M; Stitzer, M	1
O'Brien, CP; Ternes, JW	1
Bree, MP; Mello, NK; Mendelson, JH	2
Ehrman, R; O'Brien, CP; Ternes, JW	1
Bigelow, GE; Liebson, IA; McCaul, ME; Stitzer, ML	1
Kosten, TR; McMahon, TJ; Pearsall, HR; Price, LH; Rosen, MI; Wallace, EA; Woods, SW	1
Bigelow, GE; Liebson, IA; Preston, KL; Strain, EC	1
Gilmore-Thomas, K; McMillan, DE	1
Archer, S; Bidlack, JM; Seyed-Mozaffari, A; Xu, JY	1
Barta, PE; Bigelow, GE; Greenberg, BD; Lancaster, E; Pearlson, GD; Preston, KL; Schlaepfer, TE; Strain, EC	1
Hameedi, FA; Kosten, TA; Kosten, TR; Oliveto, AH; Rosen, MI; Woods, SW	1
Dahl, JL; Gilson, AM; Joranson, DE; Ryan, KM	1
Bigelow, GE; Stoller, K; Strain, EC; Walsh, SL	1
Charuvastra, VC; Compton, P; Kintaudi, K; Ling, W	1
Bigelow, GE; Stoller, KB; Strain, EC; Walsh, SL	1
Bigelow, GE; Strain, EC; Walsh, SL	1
Grabowski, J; Jordan-Hayes, J; O'Brien, CP; Ternes, JW; Wellerstein, H	1
Archer, S; Bidlack, JM; Jiang, Q; Seyed-Mozaffari, A	1
Ehrman, R; McLellan, AT; O'Brien, CP; Ternes, J	1
Bigelow, GE; Liebson, I; Preston, KL; Strain, EC	1
Bigelow, GE; Liebson, IA; Preston, KL	5
Jasinski, DR; Johnson, RE; Kocher, TR	1
Ehrman, RN; O'Brien, CP; Ternes, JW	1
Bickel, W; Bigelow, GE; Liebson, IA; Preston, KL	1
Bickel, W; Bigelow, G; Liebson, I; Preston, K	1
Bickel, WK; Bigelow, GE; Jasinski, DR; Johnson, RE; Liebson, IA; Stitzer, ML	1
Henningfield, JE; Lamb, RJ	1

Reviews

5 review(s) available for hydromorphone and Addiction, Opioid

Article	Year
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review. Harm reduction journal, 2022, 10-13, Volume: 19, Issue:1 Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Hydromorphone; Opiate Substitution Treatment; Opioid-Related Disorders	2022
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling). The International journal on drug policy, 2023, Volume: 112 Topics: Analgesics, Opioid; Health Services; Heroin; Humans; Hydromorphone; Opioid-Related Disorders	2023
Hydromorphone: evolving to meet the challenges of today's health care environment. Clinical therapeutics, 2013, Volume: 35, Issue:12 Topics: Analgesics, Opioid; Dosage Forms; Drug Administration Schedule; Humans; Hydromorphone; Opioid-Related Disorders; Pain; Pain Management; Patient Selection; United States	2013
Pain Management in the Individual with Serious Illness and Comorbid Substance Use Disorder. The Nursing clinics of North America, 2016, Volume: 51, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Comorbidity; Humans; Hydromorphone; Middle Aged; Opioid-Related Disorders; Pain Management; Pain Measurement; United States	2016
Safety and Tolerability of Once-Daily OROS(®) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies. Journal of pain and symptom management, 2012, Volume: 44, Issue:6 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Chronic Pain; Clinical Trials as Topic; Comorbidity; Evidence-Based Medicine; Female; Humans; Hydromorphone; Incidence; Male; Middle Aged; Neoplasms; Opioid-Related Disorders; Risk Assessment; Risk Factors; Severity of Illness Index; Sex Distribution; United States; Young Adult	2012

Trials

33 trial(s) available for hydromorphone and Addiction, Opioid

Article	Year
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial. Addiction science & clinical practice, 2021, 02-12, Volume: 16, Issue:1 Topics: Adult; British Columbia; Buprenorphine, Naloxone Drug Combination; Female; Humans; Hydromorphone; Male; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Research Design; Substance Withdrawal Syndrome	2021
Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone. Drug and alcohol dependence, 2021, 09-01, Volume: 226 Topics: Analgesics, Opioid; Drug Tolerance; Humans; Hydromorphone; Methadone; Opioid-Related Disorders	2021
Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder. Drug and alcohol dependence, 2017, 07-01, Volume: 176 Topics: Adult; Analgesics, Opioid; Canada; Double-Blind Method; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Hydromorphone; Injections; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Self Administration; Severity of Illness Index; Time Factors	2017
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder. Substance abuse treatment, prevention, and policy, 2017, 05-19, Volume: 12, Issue:1 Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Double-Blind Method; Female; Heroin; Humans; Hydromorphone; Male; Middle Aged; Opioid-Related Disorders; Patient Reported Outcome Measures; Sex Characteristics; Substance Abuse, Intravenous; Treatment Outcome	2017
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence. Drug and alcohol review, 2018, Volume: 37, Issue:1 Topics: Adult; Canada; Double-Blind Method; Female; Heroin; Humans; Hydromorphone; Inuit; Male; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome	2018
Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial. JAMA psychiatry, 2017, 09-01, Volume: 74, Issue:9 Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult	2017
Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals. Anesthesiology, 2019, Volume: 130, Issue:1 Topics: Adult; Analgesia; Analgesics, Opioid; Buprenorphine; Double-Blind Method; Female; Humans; Hydromorphone; Male; Opioid-Related Disorders; Pain; Treatment Outcome	2019
Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug Users. Pain medicine (Malden, Mass.), 2020, 03-01, Volume: 21, Issue:3 Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydromorphone; Male; Opioid-Related Disorders; Prodrugs	2020
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods. Journal of substance abuse treatment, 2019, Volume: 101 Topics: Analgesics, Opioid; Canada; Double-Blind Method; Heroin; Humans; Hydromorphone; Injections; Opioid-Related Disorders; Patient Acceptance of Health Care; Retrospective Studies	2019
A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial. Addiction science & clinical practice, 2014, Sep-29, Volume: 9 Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Heroin; Humans; Hydromorphone; Injections, Subcutaneous; Male; Methadone; North America; Opioid-Related Disorders; Outcome Assessment, Health Care; Research Design; Young Adult	2014
The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency. Substance abuse treatment, prevention, and policy, 2015, Jan-26, Volume: 10 Topics: Analgesics, Opioid; Double-Blind Method; Female; Heroin; Humans; Hydromorphone; Male; Opioid-Related Disorders; Patient Selection; Substance Abuse, Intravenous; Time Factors	2015
Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:1 Topics: Adult; Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydromorphone; Injections, Intramuscular; Injections, Subcutaneous; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Young Adult	2016
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. Drug and alcohol dependence, 2008, Dec-01, Volume: 98, Issue:3 Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Humans; Hydrocodone; Hydromorphone; Miosis; Oculomotor Muscles; Opioid-Related Disorders; Oxycodone; Prescription Drugs; Psychomotor Performance; Pupil	2008
Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study. Journal of substance abuse treatment, 2010, Volume: 38, Issue:4 Topics: Adult; Double-Blind Method; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Hydromorphone; Injections; Methadone; Narcotics; Opioid-Related Disorders; Pilot Projects; Severity of Illness Index; Time Factors	2010
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology, 2010, Volume: 211, Issue:3 Topics: Administration, Sublingual; Adult; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Users; Female; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Surveys and Questionnaires	2010
Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology, 2010, Volume: 211, Issue:4 Topics: Adult; Analgesics, Opioid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydromorphone; Male; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Tramadol	2010
Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:13 Topics: Adolescent; Adult; Buprenorphine; Choice Behavior; Cocaine; Cocaine-Related Disorders; Delayed-Action Preparations; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Seeking Behavior; Female; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Reinforcement Schedule; Reward; Substance Withdrawal Syndrome	2010
Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course. Drug and alcohol dependence, 2012, Jun-01, Volume: 123, Issue:1-3 Topics: Adult; Blood Pressure; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hydromorphone; Male; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Oxygen; Pupil; Respiratory Rate; Skin Temperature; Time Factors	2012
Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply. Drug and alcohol dependence, 2006, Oct-15, Volume: 85, Issue:1 Topics: Adolescent; Adult; Behavior, Addictive; Buprenorphine; Choice Behavior; Commerce; Costs and Cost Analysis; Drug Administration Schedule; Female; Heroin Dependence; Humans; Hydromorphone; Male; Middle Aged; Narcotics; Opioid-Related Disorders; Urinalysis	2006
Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biological psychiatry, 2007, Jan-01, Volume: 61, Issue:1 Topics: Adult; Analgesics, Opioid; Area Under Curve; Brain; Brain Mapping; Buprenorphine; Double-Blind Method; Drug Administration Schedule; Female; Fentanyl; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Positron-Emission Tomography; Receptors, Opioid, mu; Respiration; Time Factors; Tritium	2007
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. Psychopharmacology, 2006, Volume: 189, Issue:3 Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hydromorphone; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome	2006
Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug and alcohol dependence, 1994, Volume: 35, Issue:2 Topics: Administration, Sublingual; Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Neurologic Examination; Opioid-Related Disorders; Single-Blind Method; Substance Withdrawal Syndrome; Time Factors	1994
Opioid antagonist effects of dezocine in opioid-dependent humans. Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:2 Topics: Adult; Bridged Bicyclo Compounds, Heterocyclic; Cognition; Cycloparaffins; Humans; Hydromorphone; Male; Monitoring, Physiologic; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Psychomotor Performance; Surveys and Questionnaires; Tetrahydronaphthalenes	1996
Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects. The American journal of psychiatry, 1998, Volume: 155, Issue:4 Topics: Amygdala; Brain; Butorphanol; Cerebrovascular Circulation; Double-Blind Method; Emotions; Euphoria; Gyrus Cinguli; Humans; Hydromorphone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Placebos; Receptors, Opioid; Regional Blood Flow; Technetium Tc 99m Exametazime; Temporal Lobe; Thalamus; Tomography, Emission-Computed, Single-Photon	1998
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology, 2000, Volume: 148, Issue:4 Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Buprenorphine; Drug Combinations; Humans; Hydromorphone; Injections, Intravenous; Male; Middle Aged; Motor Activity; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Tablets; Time Factors	2000
Pain responses in methadone-maintained opioid abusers. Journal of pain and symptom management, 2000, Volume: 20, Issue:4 Topics: Adult; Cold Temperature; Drug Interactions; Female; Humans; Hydromorphone; Ketorolac; Male; Methadone; Middle Aged; Opioid-Related Disorders; Pain; Pain Measurement; Pain Threshold; Pressure; Reaction Time	2000
Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology, 2001, Volume: 154, Issue:3 Topics: Administration, Sublingual; Adolescent; Adult; Affect; Buprenorphine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Observer Variation; Opioid-Related Disorders; Psychomotor Performance; Substance Withdrawal Syndrome	2001
Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine. Psychopharmacology, 2002, Volume: 159, Issue:2 Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydromorphone; Male; Naloxone; Narcotic Antagonists; Opioid-Related Disorders	2002
Conditioned tolerance in human opiate addicts. Psychopharmacology, 1992, Volume: 108, Issue:1-2 Topics: Adult; Conditioning, Psychological; Double-Blind Method; Drug Tolerance; Galvanic Skin Response; Heart Rate; Humans; Hydromorphone; Infusions, Intravenous; Male; Opioid-Related Disorders; Self Administration; Skin Temperature; Substance Withdrawal Syndrome	1992
Clonidine in morphine withdrawal. Differential effects on signs and symptoms. Archives of general psychiatry, 1985, Volume: 42, Issue:11 Topics: Clonidine; Dose-Response Relationship, Drug; Heroin Dependence; Hospitalization; Humans; Hydromorphone; Male; Morphine; Opioid-Related Disorders; Placebos; Research Design; Substance Withdrawal Syndrome	1985
Buprenorphine and naloxone alone and in combination in opioid-dependent humans. Psychopharmacology, 1988, Volume: 94, Issue:4 Topics: Adult; Blood Pressure; Body Temperature; Buprenorphine; Cognition; Heart Rate; Humans; Hydromorphone; Male; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Respiration; Substance Withdrawal Syndrome	1988
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:2 Topics: Adult; Butorphanol; Cognition; Double-Blind Method; Humans; Hydromorphone; Injections, Intramuscular; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Substance Withdrawal Syndrome	1988
Antagonist effects of nalbuphine in opioid-dependent human volunteers. The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Methadone; Morphinans; Nalbuphine; Naloxone; Opioid-Related Disorders; Substance Withdrawal Syndrome	1989

Other Studies

67 other study(ies) available for hydromorphone and Addiction, Opioid

Article	Year
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing. The International journal on drug policy, 2021, Volume: 98 Topics: Adult; Alcoholism; Analgesics, Opioid; Canada; Female; Heroin; Housing; Humans; Hydromorphone; Opioid-Related Disorders; Retrospective Studies	2021
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada. The International journal on drug policy, 2022, Volume: 102 Topics: Adult; Analgesics, Opioid; Canada; Drug Overdose; Humans; Hydromorphone; Male; Ontario; Opioid-Related Disorders	2022
A preliminary study of hydrocodone and hydromorphone to oxycodone ratios for distinguishing impurities from independent opioid use. Clinical biochemistry, 2023, Volume: 112 Topics: Analgesics, Opioid; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Opioid-Related Disorders; Oxycodone; Oxymorphone; Tandem Mass Spectrometry	2023
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder. Addiction science & clinical practice, 2023, 02-24, Volume: 18, Issue:1 Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Hydromorphone; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain	2023
Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use. JAMA surgery, 2023, 08-01, Volume: 158, Issue:8 Topics: Adult; Analgesics, Opioid; Female; Fentanyl; Humans; Hydromorphone; Male; Middle Aged; Opioid-Related Disorders; Pain, Postoperative; Retrospective Studies	2023
Ketamine and Cognitive Behavioral Therapy for Rapid Opioid Tapering With Sustained Opioid Abstinence: A Case Report and 1-Year Follow-up. Pain practice : the official journal of World Institute of Pain, 2020, Volume: 20, Issue:1 Topics: Analgesics; Analgesics, Opioid; Cognitive Behavioral Therapy; Follow-Up Studies; Humans; Hydromorphone; Infusions, Intravenous; Ketamine; Male; Middle Aged; Opioid-Related Disorders; Pain Management; Reflex Sympathetic Dystrophy; Substance Withdrawal Syndrome	2020
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2019, Sep-23, Volume: 191, Issue:38 Topics: Analgesics, Opioid; Canada; Heroin; Humans; Hydromorphone; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Opiate Substitution Treatment; Opioid-Related Disorders; Self Administration	2019
Individual differences in human opioid abuse potential as observed in a human laboratory study. Drug and alcohol dependence, 2019, 12-01, Volume: 205 Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Female; Heroin; Humans; Hydromorphone; Individuality; Injections, Subcutaneous; Male; Middle Aged; Opioid-Related Disorders; Self Report	2019
Initiation of injectable opioid agonist treatment in hospital: A case report. Drug and alcohol review, 2020, Volume: 39, Issue:2 Topics: Analgesics, Opioid; Fentanyl; Humans; Hydromorphone; Male; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome	2020
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment. Substance abuse treatment, prevention, and policy, 2020, 01-20, Volume: 15, Issue:1 Topics: Administration, Intravenous; Adult; Attitude of Health Personnel; Female; Grounded Theory; Health Personnel; Health Status; Heroin; Humans; Hydromorphone; Interviews as Topic; Male; Middle Aged; Narcotics; Opioid-Related Disorders; Patient-Centered Care; Professional-Patient Relations; Qualitative Research	2020
Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 02-03, Volume: 192, Issue:5 Topics: Administration, Intravenous; Analgesics, Opioid; Humans; Hydromorphone; Male; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Treatment Outcome	2020
Problems with hydromorphone prescribing as a response to the opioid crisis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 03-02, Volume: 192, Issue:9 Topics: Drug Prescriptions; Fentanyl; Humans; Hydromorphone; Illicit Drugs; Narcotics; Opioid Epidemic; Opioid-Related Disorders	2020
A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada. American journal of public health, 2020, Volume: 110, Issue:6 Topics: Analgesics, Opioid; British Columbia; Community Health Centers; Drug Overdose; Harm Reduction; Humans; Hydromorphone; Opioid-Related Disorders; Public Health	2020
Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach. Drug and alcohol dependence, 2021, 01-01, Volume: 218 Topics: Adult; Analgesics, Opioid; Cocaine; Cocaine-Related Disorders; Female; Heroin; Humans; Hydromorphone; Male; Middle Aged; Opioid-Related Disorders	2021
Injectable opioid agonist treatment: An evolutionary concept analysis. Research in nursing & health, 2021, Volume: 44, Issue:4 Topics: Administration, Intravenous; Analgesics, Opioid; Canada; Harm Reduction; Heroin; Humans; Hydromorphone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders	2021
Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulfate). Drug testing and analysis, 2021, Volume: 13, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Buprenorphine; Codeine; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Saliva; Substance Abuse Detection	2021
Patients at Risk: Large Opioid Prescriptions After Total Knee Arthroplasty. The Journal of arthroplasty, 2017, Volume: 32, Issue:8 Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Drug Combinations; Drug Prescriptions; Female; Follow-Up Studies; Humans; Hydrocodone; Hydromorphone; Knee Joint; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Discharge; Reoperation; Retrospective Studies	2017
Digital ischaemia after intra-arterial drug injection. BMJ case reports, 2017, Sep-25, Volume: 2017 Topics: Buprenorphine; Constriction, Pathologic; Fingers; Humans; Hydromorphone; Injections, Intra-Arterial; Ischemia; Male; Middle Aged; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Peripheral Vascular Diseases; Toes	2017
Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS. Journal of analytical toxicology, 2018, Mar-01, Volume: 42, Issue:2 Topics: Chromatography, Liquid; Codeine; Glucuronates; Hair; Humans; Hydromorphone; Limit of Detection; Morphine Derivatives; Opioid-Related Disorders; Reproducibility of Results; Specimen Handling; Substance Abuse Detection; Tandem Mass Spectrometry	2018
Evaluation of the Relative Abuse of an OROS Extended-release Hydromorphone HCI Product: Results From 3 Postmarket Surveillance Studies. The Clinical journal of pain, 2018, Volume: 34, Issue:7 Topics: Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Hydromorphone; Male; Opioid-Related Disorders; Prevalence; Product Surveillance, Postmarketing; Severity of Illness Index	2018
Fatal Sickling Triggered by Massive Foreign Particle Embolism: A Case Report of Unrecognized Indwelling Venous Catheter Drug Abuse in Sickle Cell Disease. The American journal of forensic medicine and pathology, 2018, Volume: 39, Issue:2 Topics: Adult; Analgesics, Opioid; Anemia, Sickle Cell; Catheters, Indwelling; Fatal Outcome; Female; Foreign Bodies; Hemolysis; Humans; Hydromorphone; Opioid-Related Disorders; Pulmonary Embolism; Splenomegaly; Tablets	2018
Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid. Journal of analytical toxicology, 2018, Jul-01, Volume: 42, Issue:6 Topics: Analgesics, Opioid; Calibration; Chromatography, Liquid; Codeine; Humans; Hydrocodone; Hydromorphone; Morphine; Morphine Derivatives; Opioid-Related Disorders; Oxycodone; Oxymorphone; Predictive Value of Tests; Reference Standards; Reproducibility of Results; Saliva; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry	2018
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Addiction (Abingdon, England), 2018, Volume: 113, Issue:7 Topics: British Columbia; Cost-Benefit Analysis; Crime; Double-Blind Method; Equivalence Trials as Topic; Health Services; Heroin; Hospitalization; Humans; Hydromorphone; Methadone; Mortality; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Severity of Illness Index	2018
Employment and paid work among participants in a randomized controlled trial comparing diacetylmorphine and hydromorphone. The International journal on drug policy, 2018, Volume: 57 Topics: Adult; Double-Blind Method; Educational Status; Employment; Female; Heroin; Humans; Hydromorphone; Male; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2018
Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. Addiction (Abingdon, England), 2018, Volume: 113, Issue:7 Topics: Cost-Benefit Analysis; Heroin; Humans; Hydromorphone; Methadone; Opioid-Related Disorders	2018
Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report. A&A practice, 2019, Jan-15, Volume: 12, Issue:2 Topics: Analgesics, Opioid; Colonic Pseudo-Obstruction; Constipation; Decompression, Surgical; Humans; Hydromorphone; Intestinal Perforation; Low Back Pain; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Postoperative Complications; Quaternary Ammonium Compounds; Spinal Stenosis	2019
Parenteral Opioid Shortage - Treating Pain during the Opioid-Overdose Epidemic. The New England journal of medicine, 2018, Aug-16, Volume: 379, Issue:7 Topics: Administration, Intravenous; Analgesics, Opioid; Drug Compounding; Drug Overdose; Fentanyl; Government Regulation; Humans; Hydromorphone; Legislation, Drug; Morphine; Opioid-Related Disorders; Pain; Practice Guidelines as Topic; United States	2018
Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS. Drug and alcohol dependence, 2018, 12-01, Volume: 193 Topics: Buprenorphine; Cannabinoids; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Illicit Drugs; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Oxymorphone; Retrospective Studies; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry	2018
Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review. Pain medicine (Malden, Mass.), 2013, Volume: 14, Issue:8 Topics: Acetaminophen; Acute Pain; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesics, Opioid; Buprenorphine; Compartment Syndromes; Creatine Kinase; Drug Combinations; Glycogen Storage Disease Type V; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain Measurement; Rhabdomyolysis	2013
Chemical coping versus pseudoaddiction in patients with cancer pain. Palliative & supportive care, 2014, Volume: 12, Issue:5 Topics: Adaptation, Psychological; Adult; Analgesics, Opioid; Comorbidity; Head and Neck Neoplasms; Humans; Hydrocodone; Hydromorphone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Opioid-Related Disorders; Pain	2014
Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Middle East journal of anaesthesiology, 2013, Volume: 22, Issue:3 Topics: Acetaminophen; Adolescent; Adult; Analgesia, Obstetrical; Analgesics, Opioid; Buprenorphine; Cesarean Section; Delivery, Obstetric; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Hyperalgesia; Ibuprofen; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies; Young Adult	2013
Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse. Journal of medical Internet research, 2014, May-02, Volume: 16, Issue:5 Topics: Acetaminophen; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Combinations; Humans; Hydrocodone; Hydromorphone; Internet; Opioid-Related Disorders; Oxycodone; Social Media	2014
Effectiveness of opioid analgesics in chronic noncancer pain. Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:3 Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome	2015
A Case of Toxic Breast-feeding? Pediatric emergency care, 2019, Volume: 35, Issue:1 Topics: Analgesics, Opioid; Breast Feeding; Humans; Hydromorphone; Infant, Newborn; Milk, Human; Mothers; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Postpartum Period	2019
The epidural works, but the patient hurts! Acute pain management of the chronic pain patient. The Journal of the Arkansas Medical Society, 2009, Volume: 106, Issue:2 Topics: Acute Disease; Analgesia, Epidural; Analgesics, Opioid; Chronic Disease; Continuity of Patient Care; Drug Therapy, Combination; Fentanyl; Humans; Hydromorphone; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Opioid-Related Disorders; Pain, Postoperative; Practice Guidelines as Topic; Substance Withdrawal Syndrome	2009
Opioid conversions and patient-controlled analgesia parameters in opioid-dependent patients. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2010, Volume: 57, Issue:12 Topics: Administration, Oral; Analgesia, Patient-Controlled; Analgesics, Opioid; Dose-Response Relationship, Drug; Humans; Hydromorphone; Infusions, Intravenous; Morphine; Opioid-Related Disorders; Pain; Pain, Postoperative	2010
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Canadian family physician Medecin de famille canadien, 2011, Volume: 57, Issue:11 Topics: Analgesics, Opioid; Benzodiazepines; Canada; Chronic Pain; Codeine; Humans; Hydromorphone; Mass Screening; Opioid-Related Disorders; Oxycodone; Patient Education as Topic; Sleep Apnea Syndromes; Tramadol	2011
Prescription opioid misuse: characteristics of earliest and most recent memory of hydromorphone use. Journal of addiction medicine, 2012, Volume: 6, Issue:2 Topics: Adult; Analgesics, Opioid; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Utilization; Female; Humans; Hydromorphone; Male; Mental Recall; Methadone; Middle Aged; Motivation; Narcotics; Nova Scotia; Opioid-Related Disorders; Prescription Drugs	2012
The role of fentanyl in refractory opioid-related acute colonic pseudo-obstruction. Journal of pain and symptom management, 2013, Volume: 45, Issue:3 Topics: Aged, 80 and over; Back Pain; Colonic Pseudo-Obstruction; Drug Substitution; Female; Fentanyl; Humans; Hydromorphone; Opioid-Related Disorders; Treatment Outcome	2013
Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test. Addiction biology, 2003, Volume: 8, Issue:1 Topics: Adult; Drug Tolerance; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Saccades	2003
Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Experimental and clinical psychopharmacology, 2006, Volume: 14, Issue:2 Topics: Adult; Analgesics, Opioid; Heart Rate; Humans; Hydromorphone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Tramadol	2006
Correlates of nonmedical use of hydromorphone and hydrocodone:results from a national household survey. Journal of pain & palliative care pharmacotherapy, 2007, Volume: 21, Issue:3 Topics: Adolescent; Adult; Analgesics, Opioid; Child; Cross-Sectional Studies; Drug Combinations; Female; Health Behavior; Health Status; Humans; Hydrocodone; Hydromorphone; Male; Opioid-Related Disorders; Prevalence; Socioeconomic Factors; Substance-Related Disorders; United States	2007
Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation. Psychopharmacology, 2008, Volume: 198, Issue:2 Topics: Administration, Cutaneous; Adult; Area Under Curve; Buprenorphine; Chemistry, Pharmaceutical; Female; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome	2008
Spontaneously breathing technique for opioid tolerance. Acta anaesthesiologica Scandinavica, 2008, Volume: 52, Issue:4 Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Inhalation; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Drug Tolerance; Fentanyl; Fractures, Bone; Humans; Humerus; Hydromorphone; Intubation, Intratracheal; Ketorolac; Male; Marijuana Abuse; Methyl Ethers; Opioid-Related Disorders; Orthopedic Procedures; Pain; Respiration; Sevoflurane	2008
Zinc tannate salts of heroin, LAAM and hydromorphone attenuate opiate withdrawal syndrome. Psychopharmacology, 1980, Volume: 68, Issue:3 Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Codeine; Delayed-Action Preparations; Heroin; Humans; Hydromorphone; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Rats; Substance Withdrawal Syndrome; Zinc	1980
Dilaudid use: trends and characteristics of users. Chemical dependencies, 1980, Volume: 4, Issue:1-2 Topics: Adult; Analgesics, Opioid; Cross-Sectional Studies; Female; Florida; Heroin; Heroin Dependence; Humans; Hydromorphone; Injections, Intramuscular; Injections, Intravenous; Male; Opioid-Related Disorders; Social Class; Socioeconomic Factors; Substance-Related Disorders; Time Factors; White People	1980
Doctors & drug abusers. The Journal of the Indiana State Medical Association, 1982, Volume: 75, Issue:3 Topics: Analgesics, Opioid; Crime; Emergency Service, Hospital; Humans; Hydromorphone; Indiana; Male; Opioid-Related Disorders	1982
Physiological and subjective effects of hydromorphone in postaddict volunteers. NIDA research monograph, 1982, Volume: 41 Topics: Adult; Dose-Response Relationship, Drug; Humans; Hydromorphone; Injections, Intravenous; Male; Opioid-Related Disorders; Pupil; Respiration; Skin Temperature	1982
Psychological and physiological response to hydromorphone: an opponent process view of addiction. NIDA research monograph, 1982, Volume: 41 Topics: Affect; Humans; Hydromorphone; Opioid-Related Disorders; Skin Temperature	1982
Comparison of the effects of buprenorphine and methadone on opiate self-administration in primates. NIDA research monograph, 1982, Volume: 41 Topics: Animals; Buprenorphine; Dose-Response Relationship, Drug; Eating; Heroin Dependence; Humans; Hydromorphone; Macaca mulatta; Macaca nemestrina; Male; Methadone; Morphinans; Opioid-Related Disorders; Self Administration	1982
Comparison of buprenorphine and methadone effects on opiate self-administration in primates. The Journal of pharmacology and experimental therapeutics, 1983, Volume: 225, Issue:2 Topics: Animals; Buprenorphine; Depression, Chemical; Disease Models, Animal; Feeding Behavior; Heroin; Humans; Hydromorphone; Macaca mulatta; Macaca nemestrina; Methadone; Morphinans; Opioid-Related Disorders; Self Administration	1983
Cynomolgus monkeys do not develop tolerance to opioids. Behavioral neuroscience, 1983, Volume: 97, Issue:2 Topics: Animals; Drug Tolerance; Humans; Hydromorphone; Macaca fascicularis; Macaca mulatta; Naloxone; Opioid-Related Disorders; Species Specificity	1983
Intravenous hydromorphone: effects in opiate-free and methadone maintenance subjects. NIDA research monograph, 1983, Volume: 43 Topics: Adult; Blood Pressure; Heart Rate; Humans; Hydromorphone; Injections, Intravenous; Male; Methadone; Opioid-Related Disorders; Pupil; Respiration; Skin Temperature	1983
Stability of opioid craving over time as measured by visual analog scales. Drug and alcohol dependence, 1996, Volume: 40, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Motivation; Opioid-Related Disorders; Pain Measurement; Substance Abuse Detection; Substance Withdrawal Syndrome	1996
N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:2 Topics: Analgesics, Opioid; Animals; Benzeneacetamides; Cattle; Dose-Response Relationship, Drug; Hydromorphone; Male; Mice; Mice, Inbred ICR; Morphine; Narcotic Antagonists; Opioid-Related Disorders; Pyrrolidines; Receptors, Opioid, mu	1996
Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Experimental and clinical psychopharmacology, 1998, Volume: 6, Issue:2 Topics: Adult; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Methadone; Naloxone; Opioid-Related Disorders	1998
Trends in medical use and abuse of opioid analgesics. JAMA, 2000, Apr-05, Volume: 283, Issue:13 Topics: Analgesics, Opioid; Drug Utilization; Fentanyl; Humans; Hydromorphone; Meperidine; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Retrospective Studies; Risk Assessment; Social Change; United States	2000
Conditioned drug responses to naturalistic stimuli. NIDA research monograph, 1979, Volume: 27 Topics: Conditioning, Psychological; Heart Rate; Humans; Hydromorphone; Methadone; Naltrexone; Opioid-Related Disorders; Personality Tests; Self Administration; Skin Temperature	1979
Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO). The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:2 Topics: Analgesics; Animals; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Hydromorphone; Male; Mice; Mice, Inbred ICR; Opioid-Related Disorders; Receptors, Opioid; Receptors, Opioid, mu	1992
The effects of buprenorphine in methadone-dependent volunteers. NIDA research monograph, 1990, Volume: 105 Topics: Buprenorphine; Double-Blind Method; Humans; Hydromorphone; Male; Methadone; Naloxone; Opioid-Related Disorders; Pupil	1990
Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification. Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:2 Topics: Adult; Clonidine; Drug Administration Schedule; Humans; Hydromorphone; Male; Methadone; Opioid-Related Disorders; Oxazepam; Psychomotor Performance; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires	1985
Nondependent monkeys self-administer hydromorphone. Behavioral neuroscience, 1985, Volume: 99, Issue:3 Topics: Animals; Cocaine; Drug Tolerance; Hydromorphone; Macaca; Macaca fascicularis; Macaca mulatta; Naloxone; Opioid-Related Disorders; Species Specificity; Substance Withdrawal Syndrome; Substance-Related Disorders	1985
Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:3 Topics: Adult; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Psychological; Humans; Hydromorphone; Male; Methadone; Naloxone; Opioid-Related Disorders; Psychomotor Performance	1987
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. NIDA research monograph, 1987, Volume: 76 Topics: Butorphanol; Heart Rate; Humans; Hydromorphone; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Pupil; Respiration; Skin Temperature; Substance Withdrawal Syndrome; Surveys and Questionnaires	1987
Drug discrimination in human post-addicts: agonist/antagonist opioids. NIDA research monograph, 1988, Volume: 81 Topics: Buprenorphine; Butorphanol; Discrimination Learning; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pentazocine	1988
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:1 Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pupil; Respiration	1988
Human d-amphetamine drug discrimination: testing with d-amphetamine and hydromorphone. NIDA research monograph, 1989, Volume: 95 Topics: Adult; Arousal; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Opioid-Related Disorders; Psychomotor Performance; Substance-Related Disorders	1989